Tuesday, March 19, 2013

Less frequent mammograms don't increase risks after age 50 : study

By Julie Steenhuysen

CHICAGO (Reuters) - In the latest installment in the mammogram debate, a new study finds that getting a mammogram every other year instead of annually did not increase the risk of advanced breast cancer in women aged 50 to 74, even in women who use hormone therapy or have dense breasts, factors that increase a woman's cancer risk.

The findings, released on Monday by researchers at the University California, San Francisco, support the conclusions of the U.S. Preventive Services Task Force, an influential government panel of health advisers, which in 2009 issued guidelines that said women should have mammograms every other year starting at age 50 rather than annual tests starting at age 40.

The controversial recommendations to reduce the frequency and delay the start of mammogram screening were based on studies suggesting the benefits of detecting cancers earlier did not outweigh the risk of false positive results, which needlessly expose women to the anguish of a breast cancer diagnosis and the ordeal of treatment.

The matter, however, is not settled. The American Cancer Society still recommends women be screened for breast cancer every year they are in good health starting at age 40, but the group is closely watching studies such as this.

"I don't think any one study ought to change everything," Dr. Otis Brawley, chief medical officer of the American Cancer Society, said in a telephone interview. But he added, "This is one of several studies that are all pointing in the same direction over the last several years."

Brawley said he did not expect screening recommendations from professional organizations to change in the next year, but he does see doctors moving toward a more personalized approach over the next five years. There may be some women who need to be screened every six months and others every two years depending on their breast density, family history and genetic testing.

In the latest study, Dr. Karla Kerlikowske of the University of California, San Francisco, and colleagues wanted to see whether risk factors beyond a woman's age play a role in the decision of when to start mammogram screening.

In addition to age, the team considered whether women had dense breast tissue - which has a higher ratio of connective tissue to fat - or took combination estrogen and progesterone hormone therapy for more than five years, both of which can increase the risk of breast cancer.

"If you have these risk factors, would it help if you got screened annually vs. every two years?" said Kerlikowske, whose study was published online in JAMA Internal Medicine.

To study this, the team analyzed data from 11,474 women with breast cancer and 922,624 without breast cancer gathered from 1994 to 2008. Even after looking at these other factors, the team found no increased risk of advanced cancer in women 50 to 74 who got a mammogram every other year instead of every year.

"It didn't matter whether you screened that group every year or every two years, the risk of advanced disease or having a worse tumor was no different," Kerlikowske said.

PSYCHOLOGICAL EFFECTS

More frequent screening in these women did result in more false-positive results. Women aged 50 to 74 who had annual mammograms had a 50 percent risk of having a false-positive result over a 10-year period, but a 31 percent risk when they were screened every other year.

Studies suggest a false positive can have lasting psychological effects. A March study in the Annals of Family Medicine said, "Three years after a false-positive ?nding, women experience psychosocial consequences that range between those experienced by women with a normal mammogram and those with a diagnosis of breast cancer."

Breast density was a factor in younger women, however. When the team looked at screening frequency in women 40 to 49, they found those with extremely dense breasts who were screened every other year had a higher risk of having a more advanced cancer than those who got screened every year. Younger women also were far more likely to have false-positive results and undergo unnecessary procedures.

Without getting a mammogram in their 40s, Kerlikowske said, "women aren't going to know if they have extremely dense breasts."

Among women in their 40s, about 12 percent to 15 percent have extremely dense breast tissue. For these women, Kerlikowske said she recommends that they get a mammogram if they have other risk factors that might put her at risk of breast cancer, including having a first-degree relative that a common term, or just "close relative"? such as a mother or a sister with breast cancer.

"Once we see their breast density is high, we will offer annual mammography," she said.

The American College of Radiology and the Society of Breast Imaging, groups that represent radiologists, said the study's methodology was flawed because it used early and late breast cancers to determine the outcomes of breast screening rather than more refined measures of tumor size, nodal status and cancer stage, which could determine whether screening detected cancers at an earlier stage.

It also faulted the study for not being a closely controlled, randomized clinical trial. The study used data from the Breast Cancer Surveillance Consortium, a national mammography screening database that gathers information from community mammography clinics on millions of women.

"We're never going to have a randomized study. This is the best in terms of the type of study anyone can actually hope for," said Brawley, whose group monitors scores of breast studies from around the world each year. He said such a study would take decades and would be prohibitively expensive.

Catching cancers earlier does not always translate into lives saved, according to a November study published in the New England Journal of Medicine by Dr. Gilbert Welch of the Dartmouth Institute for Health Policy & Clinical Practice in New Hampshire.

That study suggested that as many as a third of cancers detected through routine mammograms may not be life-threatening, contradicting the deeply ingrained belief that cancer screening is always good.

Kerlikowske said the strength of her study is that it allows researchers to consider other risk factors, such as breast density, allowing doctors to offer women personalized choices about when to start breast cancer screening.

"We're trying to move it away from this idea that it all should be based on age. There should be some thoughtfulness to it," she said.

(Reporting by Julie Steenhuysen; Additional reporting by Bill Berkrot; Editing by Jilian Mincer and Douglas Royalty)

Source: http://news.yahoo.com/less-frequent-mammograms-dont-increase-risks-age-50-000253868.html

prince jessica biel Lena Dunham elton john janelle monae MBTA national signing day

Wednesday, March 6, 2013

UT Southwestern scientists make mouse model of human cancer, demonstrate cure

UT Southwestern scientists make mouse model of human cancer, demonstrate cure [ Back to EurekAlert! ] Public release date: 5-Mar-2013
[ | E-mail | Share Share ]

Contact: Deborah Wormser
deborah.wormser@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center

DALLAS March 5, 2013 UT Southwestern Medical Center scientists report the first successful blocking of tumor development in a genetic mouse model of an incurable human cancer.

"To my knowledge, this is the first time that a mouse model of a genetically defined malignant human cancer has been generated in which the formation of the tumor from beginning to end can be monitored and in which blocking the pathway cures the mouse of the tumor," said Dr. Luis Parada, chair of the department of developmental biology at UT Southwestern and senior author of the study published in Cell and online. The study's first author is Dr. Wei Mo, a postdoctoral researcher in the department.

"We showed that blocking the activity of a receptor molecule named CXCR4 in these tumors through genetic manipulation or by chemical blockade inhibited tumor development. Together, these data reveal a potential target for therapy of these uncommon but currently untreatable malignant peripheral nerve sheath tumors (MPNSTs)," Dr. Parada added.

The study is a collaboration between Dr. Parada's laboratory and that of Dr. Lu Q. Le, co-senior author of the study and assistant professor of dermatology. Dr. Le also is co-director of the adult Comprehensive Neurofibromatosis Clinic at UT Southwestern, the first such clinic in North Texas, which is part of the Simmons Comprehensive Cancer Center. The researchers noted that co-authors at The University of Texas MD Anderson Cancer Center and Baylor College of Medicine, Houston, greatly accelerated the research effort.

MPNSTs are rare but highly aggressive tumors that are resistant to therapy and are typically fatal. The malignancies can occur sporadically or in a subset of patients with a condition called neurofibromatosis 1 (NF1) one of the most commonly inherited disorders of the nervous system, which affects an estimated 1 in 3,500 people.

The severity of NF1 can vary widely, even among family members, from mild dermatological symptoms to benign tumors that wrap around nerves and can be disfiguring, debilitating, and even life-threatening, depending on where they form, Dr. Le said. In addition, individuals with an improperly-functioning NF1 gene have an increased risk of developing cancerous tumors such as MPNSTs, he said.

The researchers generated a mouse model that spontaneously develops MPNSTs and compared gene expression activity in cancerous tumors and in the precursor cells that give rise to the tumors, which are the kind of cells in which MPNSTs develop.

They found that a protein (CXCR4), which is essential for tumor growth, is more abundant in cancerous cells than in precursor cells. In addition, they found that a molecule produced by the cancer cells themselves (CXCL12) works with CXCR4 to further the growth of cancer by stimulating the expression of the cyclin D1 protein, which promotes cell division via a signaling pathway outlined in the study.

When they examined human MPNSTs, the scientists found increased expression of CXCR4 accompanied by activity in the same pathway as the one identified in the mice, the researchers said.

Next, they blocked the activity of CXCR4 in the MPNST mice using either genetic manipulation or an FDA-approved antagonist drug for CXCR4 called AMD3100. Both strategies inhibited cancer development in mice whose tumors expressed increased levels of CXCR4, and were less effective in tumors without increased CXCR4 expression. They identified the same situation in the human cancer cells, the researchers report.

"We are very encouraged by these findings because they provide us with new directions and therapeutic windows to combat this deadly cancer, where none exist today," said Dr. Le, who added that the researchers are currently planning human trials.

###

Funding was provided by the National Cancer Institute, the Department of Defense, the National Institutes of Health, the Burroughs Wellcome Fund, and the American Cancer Society.

UT Southwestern co-authors include: Dr. Jian Chen, a former postdoctoral researcher in developmental biology now a senior scientist at OriGene Technologies in Wuxi, China; Amish Patel, a graduate student of cancer biology; Dr. Liang Zhang, a postdoctoral researcher of cell biology; Vincent Chau, a medical scientist training program student of developmental biology; Yanjiao Li, a research associate of developmental biology; Dr. Woosung Cho, a postdoctoral researcher of developmental biology; Dr. Sang Kyun Lim, an instructor of developmental biology; Jing Xu, a senior research associate; and Dr. Rene McKay, an assistant professor of developmental biology.

Visit UTSW Medicine at http://www.utswmedicine.org/cancer to learn more about UTSW's clinical services for cancer. Information for the Comprehensive Neurofibromatosis Clinic is located at http://www.utswmedicine.org/conditions-specialties/cancer/programs/neurofibromatosis/.

About UT Southwestern Medical Center

UT Southwestern, one of the premier medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty includes many distinguished members, including five who have been awarded Nobel Prizes since 1985. Numbering more than 2,700, the faculty is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in 40 specialties to nearly 100,000 hospitalized patients and oversee more than 2.1 million outpatient visits a year.

This news release is available on our World Wide Web home page at http://www.utsouthwestern.edu/home/news/index.html

To automatically receive news releases from UT Southwestern via email, subscribe at http://www.utsouthwestern.edu/receivenews


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


UT Southwestern scientists make mouse model of human cancer, demonstrate cure [ Back to EurekAlert! ] Public release date: 5-Mar-2013
[ | E-mail | Share Share ]

Contact: Deborah Wormser
deborah.wormser@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center

DALLAS March 5, 2013 UT Southwestern Medical Center scientists report the first successful blocking of tumor development in a genetic mouse model of an incurable human cancer.

"To my knowledge, this is the first time that a mouse model of a genetically defined malignant human cancer has been generated in which the formation of the tumor from beginning to end can be monitored and in which blocking the pathway cures the mouse of the tumor," said Dr. Luis Parada, chair of the department of developmental biology at UT Southwestern and senior author of the study published in Cell and online. The study's first author is Dr. Wei Mo, a postdoctoral researcher in the department.

"We showed that blocking the activity of a receptor molecule named CXCR4 in these tumors through genetic manipulation or by chemical blockade inhibited tumor development. Together, these data reveal a potential target for therapy of these uncommon but currently untreatable malignant peripheral nerve sheath tumors (MPNSTs)," Dr. Parada added.

The study is a collaboration between Dr. Parada's laboratory and that of Dr. Lu Q. Le, co-senior author of the study and assistant professor of dermatology. Dr. Le also is co-director of the adult Comprehensive Neurofibromatosis Clinic at UT Southwestern, the first such clinic in North Texas, which is part of the Simmons Comprehensive Cancer Center. The researchers noted that co-authors at The University of Texas MD Anderson Cancer Center and Baylor College of Medicine, Houston, greatly accelerated the research effort.

MPNSTs are rare but highly aggressive tumors that are resistant to therapy and are typically fatal. The malignancies can occur sporadically or in a subset of patients with a condition called neurofibromatosis 1 (NF1) one of the most commonly inherited disorders of the nervous system, which affects an estimated 1 in 3,500 people.

The severity of NF1 can vary widely, even among family members, from mild dermatological symptoms to benign tumors that wrap around nerves and can be disfiguring, debilitating, and even life-threatening, depending on where they form, Dr. Le said. In addition, individuals with an improperly-functioning NF1 gene have an increased risk of developing cancerous tumors such as MPNSTs, he said.

The researchers generated a mouse model that spontaneously develops MPNSTs and compared gene expression activity in cancerous tumors and in the precursor cells that give rise to the tumors, which are the kind of cells in which MPNSTs develop.

They found that a protein (CXCR4), which is essential for tumor growth, is more abundant in cancerous cells than in precursor cells. In addition, they found that a molecule produced by the cancer cells themselves (CXCL12) works with CXCR4 to further the growth of cancer by stimulating the expression of the cyclin D1 protein, which promotes cell division via a signaling pathway outlined in the study.

When they examined human MPNSTs, the scientists found increased expression of CXCR4 accompanied by activity in the same pathway as the one identified in the mice, the researchers said.

Next, they blocked the activity of CXCR4 in the MPNST mice using either genetic manipulation or an FDA-approved antagonist drug for CXCR4 called AMD3100. Both strategies inhibited cancer development in mice whose tumors expressed increased levels of CXCR4, and were less effective in tumors without increased CXCR4 expression. They identified the same situation in the human cancer cells, the researchers report.

"We are very encouraged by these findings because they provide us with new directions and therapeutic windows to combat this deadly cancer, where none exist today," said Dr. Le, who added that the researchers are currently planning human trials.

###

Funding was provided by the National Cancer Institute, the Department of Defense, the National Institutes of Health, the Burroughs Wellcome Fund, and the American Cancer Society.

UT Southwestern co-authors include: Dr. Jian Chen, a former postdoctoral researcher in developmental biology now a senior scientist at OriGene Technologies in Wuxi, China; Amish Patel, a graduate student of cancer biology; Dr. Liang Zhang, a postdoctoral researcher of cell biology; Vincent Chau, a medical scientist training program student of developmental biology; Yanjiao Li, a research associate of developmental biology; Dr. Woosung Cho, a postdoctoral researcher of developmental biology; Dr. Sang Kyun Lim, an instructor of developmental biology; Jing Xu, a senior research associate; and Dr. Rene McKay, an assistant professor of developmental biology.

Visit UTSW Medicine at http://www.utswmedicine.org/cancer to learn more about UTSW's clinical services for cancer. Information for the Comprehensive Neurofibromatosis Clinic is located at http://www.utswmedicine.org/conditions-specialties/cancer/programs/neurofibromatosis/.

About UT Southwestern Medical Center

UT Southwestern, one of the premier medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty includes many distinguished members, including five who have been awarded Nobel Prizes since 1985. Numbering more than 2,700, the faculty is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in 40 specialties to nearly 100,000 hospitalized patients and oversee more than 2.1 million outpatient visits a year.

This news release is available on our World Wide Web home page at http://www.utsouthwestern.edu/home/news/index.html

To automatically receive news releases from UT Southwestern via email, subscribe at http://www.utsouthwestern.edu/receivenews


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2013-03/usmc-uss030513.php

luck sag awards 2012 nominees pro bowl 2012 roster yamaguchi road house occupy oakland occupy oakland

Wednesday, January 16, 2013

German economic woes erode market gains

LONDON (AP) ? Evidence that Germany's economy contracted in the last three months of 2012 hurt global stock markets on Tuesday, offsetting more upbeat U.S. figures showing retail sales rose during the holiday month of December.

Germany's main stock index, the DAX, fell 0.7 percent to close at 7,675.91 after the government said the economy grew only 0.7 percent in 2012, which indicates activity dropped in the last three months of the year by as much as 0.5 percent. The government did not break out the quarterly figure.

The figures show the European financial crisis is weighing down even the strongest economies on the continent. Analysts, however, say the country is unlikely to fall into recession, defined as two consecutive quarters of economic contraction.

"The German economy will continue to steer its course this year ? despite a very weak year-end 2012," said Andreas Rees, chief German economist at UniCredit.

Elsewhere in Europe, Britain's FTSE 100 closed 0.2 percent higher at 6,117.31 while France's CAC-40 lost 0.3 percent to 3,697.35.

Wall Street traded lower, with the Dow shedding 0.1 percent to 13,500.36 and the broader S&P 500 losing 0.1 percent to 1,469.17 after a report showed retail sales rose 0.5 percent in December from the previous month.

The increase shows the drawn-out "fiscal cliff" debate in the U.S. had little impact on consumer spending. A series of tax hikes and spending cuts, due to come into effect Jan. 1, were only averted by a last-minute deal. The positive effect of the figures on market sentiment was not strong enough, however, to bring stock indexes into positive territory.

Earlier in Tokyo, the Nikkei 225 rose 0.7 percent to finish at 10,879.08, its highest close in nearly three years, after Masaaki Shirakawa, governor of Japan's central bank, pledged to take action to combat the country's deflationary slump.

In a boost for Japanese exporters, the yen has slid against the U.S. dollar and euro since the Liberal Democratic Party returned to power in national elections last month. Its leader, Shinzo Abe, has been lobbying the central bank for aggressive action to end Japan's years of deflation, demanding that it meet an inflation target of about 2 percent.

In announcing a 20 trillion yen ($225 billion) economic stimulus package last Friday, Abe reiterated his calls for the Bank of Japan to do more to boost growth.

Monetary stimulus programs in major economies have helped buoy stock markets over the past year and Federal Reserve Chairman Ben Bernanke was careful this week not to suggest his own central bank's efforts were ending.

In a speech in the U.S. on Monday, Bernanke made no mention of winding down the Fed's bond-buying program, dubbed quantitative easing, even though some Fed officials recently said they favor doing that.

The Fed has been buying $85 billion a month in Treasurys and mortgage bonds to try to keep borrowing costs low and encourage more spending.

Analysts at Credit Agricole CIB said markets found some relief in Bernanke's speech as it did not repeat the views of some Fed officials in hinting at an early ending of quantitative easing.

Looking ahead, investors will on Friday assess a slew of data for signs of growth in China, the world's second-largest economy. China will issue fourth-quarter growth data for 2012 as well as GDP growth for the year. Factory output, investment and retail sales will also be released.

Elsewhere in Asia, Australia's S&P/ASX 200 fell 0.1 percent to 4,716.60 and South Korea's Kospi dropped 1.1 percent to 1,986. Hong Kong's Hang Seng shed 0.1 percent to 23,381.51.

Benchmarks in Indonesia, mainland China and New Zealand rose while the Philippines, Taiwan and Singapore fell.

Benchmark oil for February delivery was down 41 cents to $93.73 per barrel in electronic trading on the New York Mercantile Exchange.

In currencies, the euro fell to $1.3342 from $1.3378 late Monday in New York. The dollar fell against the Japanese yen to 88.69 yen from 89.41 yen.

___

Pamela Sampson in Bangkok contributed to this report.

Source: http://news.yahoo.com/german-economic-woes-erode-market-gains-114932735--finance.html

Karlie Redd guild wars 2 adrian gonzalez Jerry Nelson Foo Canoodle Isaac path

Friday, January 4, 2013

Bieber calls for tough rules after paparazzo death

FILE - In this Nov. 18, 2012 file photo, Justin Bieber arrives at the 40th Anniversary American Music Awards in Los Angeles. Police say a paparazzo was hit by a car and killed after taking photos of Justin Bieber's white Ferrari on a Los Angeles street Tuesday evening Jan. 1, 2013. Los Angeles police Officer James Stoughton says the photographer, who was not identified, died at a hospital shortly after the crash Tuesday evening. Stoughton says Bieber was not in the Ferrari at the time. (Photo by Jordan Strauss/Invision/AP, File)

FILE - In this Nov. 18, 2012 file photo, Justin Bieber arrives at the 40th Anniversary American Music Awards in Los Angeles. Police say a paparazzo was hit by a car and killed after taking photos of Justin Bieber's white Ferrari on a Los Angeles street Tuesday evening Jan. 1, 2013. Los Angeles police Officer James Stoughton says the photographer, who was not identified, died at a hospital shortly after the crash Tuesday evening. Stoughton says Bieber was not in the Ferrari at the time. (Photo by Jordan Strauss/Invision/AP, File)

FILE - Canadian singer Justin Bieber attends at the Premiere of his film 'Justin Bieber: Never Say Never' in this Feb. 17, 2011 file photo taken in Paris. Police say a paparazzo was hit by a car and killed after taking photos of Justin Bieber's white Ferrari on a Los Angeles street Tuesday evening Jan. 1, 2013. Los Angeles police Officer James Stoughton says the photographer, who was not identified, died at a hospital shortly after the crash Tuesday evening. Stoughton says Bieber was not in the Ferrari at the time. (AP Photo/Jacques Brinon, File)

LOS ANGELES (AP) ? The 29-year-old photographer had just snapped shots of Justin Bieber's exotic white Ferrari when he was struck and killed by a passing car ? a death that has spurred renewed debate over dangers paparazzi can bring on themselves and the celebrities they chase.

The accident prompted some stars including the teen heartthrob himself on Wednesday to renew their calls for tougher laws to rein in their pursuers, though previous urgings have been stymied by First Amendment protections.

In a statement, Bieber said his prayers were with the photographer's family. Ironically, the singer wasn't even in the Ferrari on Tuesday.

"Hopefully this tragedy will finally inspire meaningful legislation and whatever other necessary steps to protect the lives and safety of celebrities, police officers, innocent public bystanders, and the photographers themselves," Bieber said in the statement released by Island Def Jam Music Group.

Authorities have withheld the name of the photographer, killed after being hit by a Toyota Highlander, pending notification of relatives.

Much of Hollywood was abuzz about the death, including Miley Cyrus, who sent several tweets critical of some of the actions of paparazzi and lamenting that the unfortunate accident was "bound to happen."

"Hope this paparazzi/JB accident brings on some changes in '13," Cyrus said on her Twitter page. "Paparazzi are dangerous! Wasn't Princess Di enough of a wake-up call?!"

Paparazzi roaming the streets of Southern California have been commonplace for more than a decade as the shutterbugs looked to land exclusive shots that can fetch hundreds of thousands of dollars.

Industry veterans recalled incidents where paparazzi chasing celebrities have been injured, but they couldn't remember a photographer being killed while working.

"Here in the state of California, I'm surprised this hasn't happened before," said Giles Harrison, a celebrity photographer and owner of London Entertainment Group.

Harrison is familiar with the backlash against paparazzi. He and another photographer were convicted of misdemeanor false imprisonment and sentenced to jail for boxing in Arnold Schwarzenegger and his family as they sat in their Hummer in 1998.

Citing that incident and the death of Princess Diana, the state Legislature passed its first anti-paparazzi measure a year later. It created hefty civil penalties that could be paid to stars whose privacy was invaded.

Six months ago, a paparazzo was charged with reckless driving in a high-speed pursuit of Bieber and with violating a separate, 2010 state law that toughened punishment for those who drive dangerously in pursuit of photos for commercial gain.

However, a judge last month dismissed the paparazzi law charges, saying the law was overly broad.

The judge cited problems with the statute, saying it was aimed at newsgathering activities protected by the First Amendment, and lawmakers should have increased penalties for reckless driving rather than target those who photograph celebrities.

City prosecutors said they would appeal the judge's ruling.

The law was prompted by the experiences of Jennifer Aniston, who provided details to a lawmaker about being unable to drive away after she was surrounded by paparazzi on Pacific Coast Highway.

On Tuesday, a friend of Bieber's was behind the wheel of the Ferrari when a California Highway Patrol officer pulled it over for speeding along Interstate 405, authorities said.

"This photographer evidently had been following the white Ferrari" and when it was pulled over after sundown he stopped, parked and crossed the street to snap photos, Los Angeles police Detective Charles Walton said.

The photographer stood on a low freeway railing to shoot photographs of the traffic stop over a chain-link fence, authorities said.

"The CHP officer told him numerous times that it wasn't safe for him to be there and to return to his vehicle," Walton said.

There were no sidewalks or pedestrian crossings along the street where the photographer had parked, so the driver of the car that struck him had no reason to expect a pedestrian, Walton said of the accident.

"It would have been very difficult for her to see him," the detective said.

It wasn't immediately clear how fast the motorist, a 69-year-old woman, was traveling, but she was not believe to be at fault and was unlikely to be cited, police said.

Harrison said he routinely tells his photographers to be safe when they are working.

"In any job you have to exercise a degree of common sense and caution," he said.

Harrison hopes celebrities and paparazzi examine their actions to ensure a similar event doesn't happen again. No photo is worth someone's life, he said.

"Everybody wants to be the first one to get that shot, get that scoop," Harrison said. "But at the end of the day, you can't spend money if you are dead."

___

Associated Press Writer Robert Jablon contributed to this report.

Associated Press

Source: http://hosted2.ap.org/APDEFAULT/386c25518f464186bf7a2ac026580ce7/Article_2013-01-03-Paparazzo-Killed/id-1281e7291df64720b2d800b78b336c84

bret michaels pekingese tcu football westminster bonnaroo 2012 lineup twisted metal sea lion

New health laws praised | law, abuse, elder - Life - The Orange ...

New health-related California laws will force insurers to cover mammograms for younger women, require nursing homes to quickly report elder abuse to police, and protect lactating mothers from workplace discrimination.

Here's a look at local reaction to some of the 2013 legislation:

Entertainer Mickey Rooney testified on Capitol Hill in Washington, Wednesday, March 2, 2011, about elder abuse, before the Senate Aging Committee.

FILE: ALEX BRANDON, ASSOCIATED PRESS

ADVERTISEMENT

ELDER ABUSE

AB40 resolves a longstanding conflict between state and federal laws related to elder-abuse reports, according to the office of Assemblywoman Mariko Yamada, the Northern California Democrat who authored the bill. The law took effect Jan. 1.

When elder abuse occurs in a nursing home, employees are required by law to file a report with the police or the long-term care ombudsman. When reports go to the ombudsman, strict federal confidentiality rules prevent the ombudsman from sending the report to law enforcement for a criminal investigation. The new law requires long-term care facilities to report suspected abuse that results in serious injury within two hours to police.

Kerry Burnight, a UC Irvine gerontologist, said it's unknown how often elder abuse occurs within nursing homes. In Orange County, 28,000 older adults live in long-term care facilities. In private residences, 800 elder abuse complaints are made each month, she said.

"Dementia is the greatest risk factor of elder abuse," Burnight said. "It's really important to listen to older adults; even with dementia, if they express fear or concern, to dig into it more."

Burnight said abuse can occur because some people with cognitive impairment may be resistant to care. They can also be perceived as "less than."

"We see elder abuse in multimillion-dollar homes in Newport and in the most expensive facilities," Burnight said. "It's really across the board of economic strata and all ethnicities."

BREAST-FEEDING

Previous law allows working mothers a reasonable amount of break time to pump breast milk. Additionally, employers must make a reasonable effort to provide a private place other than a toilet stall.

But AB2386, which took effect Jan. 1, forbids employers from discriminating against or harassing an employee due to breast-feeding.

Todd Scherwin, an Irvine labor lawyer, said state law forbids an employer to discriminate on the basis of sex, which includes gender, pregnancy and childbirth. The law expands the definition of "sex" to include breast-feeding.

Scherwin said the change in law was triggered by a 2009 case where a cashier at a Los Angeles taqueria was fired for nursing her premature infant during her lunch break. The Fair Employment and Housing Commission found that she experienced discrimination on the basis of her sex. The employer was fined and ordered to pay her back wages.

"I think employers just need to be more cognizant of making sure they're allowing proper space and proper time and whether it's conscious or subconscious, they're not doing anything that would be seen as retaliation or discrimination against a mother who returns to work and needs that time to breast-feed or pump," Scherwin said.

MAMMOGRAMS

Health plans were already required to cover mammograms, but AB137 removes age guidelines and calls for insurers to provide policyholders with information on when they should be screened for breast cancer.

The law goes into effect July 1.

Lisa Wolter, executive director of Orange County's affiliate of Susan G. Komen for the Cure, said some women under 40 with health insurance have been unable to get mammograms. The American Cancer Society recommends that women begin getting an annual mammogram at 40.

Wolter said in some cases Komen has paid for mammograms for those younger women with high risk or a family history of breast cancer even though they were insured.

"It's difficult for them to get a mammogram approved under their insurance," she said. "The benefit of this law is that rather than defining this by age, it defines it by need as determined by their medical provider."

She also praised the provision in the law that requires health plans to reach out to women about breast cancer screenings either by letters, phone calls or information in a newsletter.

"We do like that it does require education on the recommended timeline," she said. "Anything that will remind a woman that this is an important part of her health care."

Contact the writer: cperkes@ocregister.com 714-796-3686


Source: http://www.ocregister.com/articles/law-382380-abuse-elder.html

fast times at ridgemont high fast times at ridgemont high soylent green phil davis george st pierre aldon smith friday night lights

Thursday, January 3, 2013

Business Continuity and Disaster Recovery ? A Business Not a ...

Hackers, hurricanes, fires, flooding, power outages, denial of service attacks, application failures, employee error, sabotage and now terrorism are helping companies to focus on the necessity of a business continuity plan.

Through the late 1990s as companies prepared for Y2K, many IT executives, risk managers, CFOs and corporate managers realized that recovering computing systems, networks and data was not enough. As Y2K approached, it became more apparent that a disciplined approach was needed to recover not only data and systems, but also business processes, facilities and manpower to restore and maintain critical functions.

The starting point is a risk assessment. Identify and define your mission critical business processes and systems. Review them for vulnerabilities and identify steps required for restoration and recovery. For your data, make sure it is backed up to secure and separate locations. Evaluate various storage solutions including storage area networks, data replication systems, new virtualization systems, network attached storage devices and managed storage. Pay significant attention also to your telecommunications providers to ensure they have built diversity and redundancy into their networks and have well developed and tested contingency plans.

The risk assessment will start to drive out real questions on the business impacts and losses

that could result from disruptions. Mission critical impacts, key business functions, processes and records must all be identified. This is also the time to determine resource requirements and acceptable recovery time frames.

Various recovery strategies should be evaluated to achieve your cost, reliability and time to recover objectives. Include physical, technological, legal, regulatory and personnel considerations when you evaluate alternatives. Common points of failure are a lack of executive and budget support and not fully engaging employees. Along with your data, employees are your most valuable asset. An excellent checklist ?Considerations for senior management during a time of crisis? is at www.globalcontinuity.com (enter checklists in the search box, click on DR & BC checklists).

Business continuity planning sounds expensive and it can be time-consuming. However, losing your business functions, processes and systems as well as your company, customer and financial data can be devastating. Build your plan. Train, test, train and test again.

About The Author

Robert Mahood has significant technology and management experience in data communications, internet, storage, disaster recovery and data recovery. He is currently the president of Midwest Data Recovery. www.midwestdatarecovery.com

bmahood@midwestdatarecovery.com, 866 786 2595 or 312 907 2100

Source: http://www.mwstm.com/2013/01/02/Business-Continuity-and-Disaster-Recovery-A-Business-Not-a-Technology-Issue/

Election 2012 Results polling place washington post comedy central philadelphia eagles obamacare Todd Akin

Cute quotient overload: eyes-on with the Street Fighter x Sanrio Fightstick for Xbox 360

Cute quotient overload eyeson with the Street Fighter x Sanrio Fightstick for Xbox 360

Thought the holidays were over? So did we. Imagine our surprise, then, when we returned to the office to find one last, special package lying in wait: Mad Catz Street Fighter x Sanrio Arcade Fightstick Pro. As ridiculous explosions of cute go, this one takes the sugoku kawaii cake -- even the box is a Hello Kitty collector's wet dream. Obvious overall otaku appeal aside, Xbox 360 gamers interested in the Fightstick Pro will find an eight button "authentic Japanese-style Sanwa Denshi" layout, switches for button lock / unlock and three joystick configuration settings (d-pad, left or right analog stick), turbo functionality, as well as a 3.5mm headphone jack upfront and a storage compartment housing the 13-foot long USB cable around back. Really though, no amount of English words will do this kitsch item justice. So check out the gallery below for a photo tour of this adorable collision of anime worlds.

Filed under:

Comments

Source: http://feeds.engadget.com/~r/weblogsinc/engadget/~3/swPW1adRksw/

tom hardy British Open leaderboard Jessica Ghawi People Water Fred Willard Emmy nominations 2012 Ramadan 2012